Wellness clinic IV drips linked to bacterial toxin poisoning in multiple states
More than 30 patients in four states fell ill after receiving glutathione IV drips that were contaminated with bacterial toxins.
Over 30 individuals across four unnamed states were poisoned by bacterial toxins after receiving intravenous glutathione drips at wellness clinics. The CDC and FDA traced the problem to compounding pharmacies that used glutathione powder intended for oral dietary supplements, not for sterile injections. This misgrading allowed bacterial contamination to enter the IV solutions.
The glutathione was supplied by Medisca Inc., headquartered in Plattsburgh, New York, which later warned its pharmacy customers against using the product for injectable purposes. No FDA-approved glutathione products exist for injection in the United States, yet the compound is marketed for detoxification, immune support, and other claimed benefits. Officials are investigating the extent of the outbreak and urging clinics to cease using the unsafe formulation.
Why it matters
The incident highlights risks of unregulated compounding practices and unsafe wellness-clinic treatments.
In this story
